Quarterly report pursuant to Section 13 or 15(d)

Consolidating Condensed Financial Information of Guarantor Subsidiaries (Details 2)

v2.4.0.6
Consolidating Condensed Financial Information of Guarantor Subsidiaries (Details 2) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jun. 23, 2012
Jun. 25, 2011
Condensed Cash Flows Statement on the Company's understanding of the SEC    
Net cash provided (used) by operating activities $ 64,154 $ (1,503)
Additions to property and equipment (26,930) (20,191)
Businesses acquired, net of cash acquired 0 24,432
Investment in guarantor subsidiaries 0 0
Net cash used by investing activities (26,930) (44,623)
Proceeds from issuance of long-term debt 49,288 0
Repayments of long-term debt (266) (221)
Borrowings under revolving line of credit 304,000 593,000
Repayments under revolving line of credit (339,000) (543,000)
Repurchase of common stock (23,151) (83,602)
Proceeds from issuance of common stock 1,291 1,436
Payment of financing costs (1,715) (1,034)
Excess tax benefits from stock-based awards 938 791
Distribution to noncontrolling interest 0 (1,500)
Net cash used in financing activities (8,615) (34,130)
Effect of exchange rate changes on cash 59 29
Net increase (decrease) in cash and cash equivalents 28,668 (80,227)
Cash and equivalents at beginning of period 12,031 91,460
Cash and equivalents at end of period 40,699 11,233
Parent [Member]
   
Condensed Cash Flows Statement on the Company's understanding of the SEC    
Net cash provided (used) by operating activities 64,057 61,141
Additions to property and equipment (13,607) (10,901)
Businesses acquired, net of cash acquired   23,403
Investment in guarantor subsidiaries (17,475) 73,372
Net cash used by investing activities (31,082) (107,676)
Proceeds from issuance of long-term debt 49,288  
Repayments of long-term debt (175) (93)
Borrowings under revolving line of credit 304,000 593,000
Repayments under revolving line of credit (339,000) (543,000)
Repurchase of common stock (23,151) (83,602)
Proceeds from issuance of common stock 1,291 1,436
Payment of financing costs (1,715) (1,034)
Excess tax benefits from stock-based awards 938 791
Distribution to noncontrolling interest   (1,500)
Net cash used in financing activities (8,524) (34,002)
Effect of exchange rate changes on cash 79 394
Net increase (decrease) in cash and cash equivalents 24,530 (80,143)
Cash and equivalents at beginning of period 10,633 90,265
Cash and equivalents at end of period 35,163 10,121
Guarantor Subsidiaries [Member]
   
Condensed Cash Flows Statement on the Company's understanding of the SEC    
Net cash provided (used) by operating activities 46,004 (5,856)
Additions to property and equipment (13,323) (9,290)
Businesses acquired, net of cash acquired   1,029
Investment in guarantor subsidiaries (28,432) (16,584)
Net cash used by investing activities (41,755) 6,265
Proceeds from issuance of long-term debt 0  
Repayments of long-term debt (91) (128)
Borrowings under revolving line of credit 0 0
Repayments under revolving line of credit 0 0
Repurchase of common stock 0 0
Proceeds from issuance of common stock 0 0
Payment of financing costs 0 0
Excess tax benefits from stock-based awards 0 0
Distribution to noncontrolling interest   0
Net cash used in financing activities (91) (128)
Effect of exchange rate changes on cash (20) (365)
Net increase (decrease) in cash and cash equivalents 4,138 (84)
Cash and equivalents at beginning of period 1,398 1,195
Cash and equivalents at end of period 5,536 1,112
Eliminations [Member]
   
Condensed Cash Flows Statement on the Company's understanding of the SEC    
Net cash provided (used) by operating activities (45,907) (56,788)
Additions to property and equipment 0 0
Businesses acquired, net of cash acquired   0
Investment in guarantor subsidiaries 45,907 (56,788)
Net cash used by investing activities 45,907 56,788
Proceeds from issuance of long-term debt 0  
Repayments of long-term debt 0 0
Borrowings under revolving line of credit 0 0
Repayments under revolving line of credit 0 0
Repurchase of common stock 0 0
Proceeds from issuance of common stock 0 0
Payment of financing costs 0 0
Excess tax benefits from stock-based awards 0 0
Distribution to noncontrolling interest   0
Net cash used in financing activities 0 0
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and equivalents at beginning of period 0 0
Cash and equivalents at end of period $ 0 $ 0